Compound Detail
CHEMBL5314346
VERTEPORFIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL5314346 |
| Name | VERTEPORFIN |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
7
Known Names
19
Indications
1
Mechanisms
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2000 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| DNA inhibitor | INHIBITOR | DNA | ✓ | ✓ |
Indications
Macular Degeneration Macular Degeneration Myopia, Degenerative Myopia, Degenerative Retinal Neovascularization Wet Macular Degeneration Basal Cell Nevus Syndrome Carcinoma, Basal Cell Choroidal Neovascularization Breast Neoplasms Histoplasmosis Pancreatic Neoplasms Pancreatic Neoplasms Central Nervous System Neoplasms Glioblastoma Melanoma Neoplasms Pleural Effusion Prostatic Neoplasms, Castration-Resistant
ATC Classification
S01LA01
verteporfin
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Data from ChEMBL 36 via Core Engine